BrightPath Biotherapeutics Co., Ltd.

TSE:4594.T

51 (JPY) • At close September 13, 2024
Bedrijfsnaam BrightPath Biotherapeutics Co., Ltd.
Symbool 4594.T
Munteenheid JPY
Prijs 51
Beurswaarde 4,222,356,249
Dividendpercentage 0%
52-weken bereik 43 - 148
Industrie Biotechnology
Sector Healthcare
CEO Mr. Kenichi Nagai
Website https://www.brightpathbio.com

An error occurred while fetching data.

Over BrightPath Biotherapeutics Co., Ltd.

BrightPath Biotherapeutics Co., Ltd. develops cancer immunotherapy drugs. The company is developing GRN-1201 that is in Phase II clinical study for the treatment of non-small cell lung cancer, as well as in Phase I clinical study to treat melanoma. It also develops BP1101, a neoantigen vaccine; BP1209, a platform of

Vergelijkbare Aandelen

TOWA Hi SYSTEM CO.,LTD. logo

TOWA Hi SYSTEM CO.,LTD.

4172.T

1,856 JPY

Welby Inc. logo

Welby Inc.

4438.T

390 JPY

Yamashita Health Care Holdings,Inc. logo

Yamashita Health Care Holdings,Inc.

9265.T

2,561 JPY

UCHIYAMA HOLDINGS Co.,Ltd. logo

UCHIYAMA HOLDINGS Co.,Ltd.

6059.T

330 JPY

teno. Holdings Company Limited logo

teno. Holdings Company Limited

7037.T

484 JPY

Sincere Co., LTD. logo

Sincere Co., LTD.

7782.T

398 JPY

Artra Group Corporation logo

Artra Group Corporation

6029.T

141 JPY

baby calendar Inc. logo

baby calendar Inc.

7363.T

1,430 JPY

Pharmarise Holdings Corporation logo

Pharmarise Holdings Corporation

2796.T

608 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)